1 Min Read
April 24 (Reuters) - Lipocine Inc
* Lipocine completes enrollment in the LPCN 1021 fixed dose clinical trials
* To announce top-line results from LPCN 1021 fixed dose clinical trials in June 2017 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.